The IRS evaluation of STAT3 (Figure 5A) revealed a significant downregulation of STAT3 in PCa (mean IRS ± SD: 4.9 ± 3.0) compared to BPH (mean IRS ± SD: 7.1 ± 2.5). The gene discussed is STAT3; the disease is benign prostatic hyperplasia.